A P Watt - JoVE Visualize

Showing results (11-20 of 28) with videos related to

Pageof 3

Sort By:

Journal of Neurochemistry|November 1, 1992

Measurement of lithium-induced changes in mouse inositol(1)phosphate levels in vivoJ R Atack, S M Cook, A P Watt, et al.

Journal of Neurochemistry|February 1, 1993

In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330J R Atack, S M Cook, A P Watt, et al.

Thorax|February 27, 2004

Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasisA P Watt, V Brown, J Courtney, et al.

Bioorganic & Medicinal Chemistry Letters|November 21, 2001

2-Aryl indole NK(1) antagonists: optimisation of the amide substituentD Shaw, G G Chicchi, J M Elliott, et al.

Journal of Medical Microbiology|November 19, 2011

False-positive PCR results linked to administration of seasonal influenza vaccineT Curran, C McCaughey, J Ellis, et al.

Journal of Medicinal Chemistry|May 12, 1995

Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptorsL J Street, R Baker, W B Davey, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996

Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complexL J Bristow, P H Hutson, J J Kulagowski, et al.

Journal of Medicinal Chemistry|August 1, 1997

5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.

Journal of Medicinal Chemistry|December 10, 1999

3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonistsM G Russell, V G Matassa, R R Pengilley, et al.

Journal of Medicinal Chemistry|March 3, 1999

Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptorF Sternfeld, A R Guiblin, R A Jelley, et al.

Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:

Pageof 3

Journal of Neurochemistry|November 1, 1992

Measurement of lithium-induced changes in mouse inositol(1)phosphate levels in vivoJ R Atack, S M Cook, A P Watt, et al.

Journal of Neurochemistry|February 1, 1993

In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330J R Atack, S M Cook, A P Watt, et al.

Thorax|February 27, 2004

Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasisA P Watt, V Brown, J Courtney, et al.

Bioorganic & Medicinal Chemistry Letters|November 21, 2001

2-Aryl indole NK(1) antagonists: optimisation of the amide substituentD Shaw, G G Chicchi, J M Elliott, et al.

Journal of Medical Microbiology|November 19, 2011

False-positive PCR results linked to administration of seasonal influenza vaccineT Curran, C McCaughey, J Ellis, et al.

Journal of Medicinal Chemistry|May 12, 1995

Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptorsL J Street, R Baker, W B Davey, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996

Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complexL J Bristow, P H Hutson, J J Kulagowski, et al.

Journal of Medicinal Chemistry|August 1, 1997

5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.

Journal of Medicinal Chemistry|December 10, 1999

3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonistsM G Russell, V G Matassa, R R Pengilley, et al.

Journal of Medicinal Chemistry|March 3, 1999

Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptorF Sternfeld, A R Guiblin, R A Jelley, et al.

Pageof 3